Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1716627rdf:typepubmed:Citationlld:pubmed
pubmed-article:1716627lifeskim:mentionsumls-concept:C0230840lld:lifeskim
pubmed-article:1716627lifeskim:mentionsumls-concept:C0003075lld:lifeskim
pubmed-article:1716627lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:1716627pubmed:issue26lld:pubmed
pubmed-article:1716627pubmed:dateCreated1991-10-21lld:pubmed
pubmed-article:1716627pubmed:abstractTextThe inner membrane of liver and heart mitochondria possesses an anion uniport pathway, known as the inner membrane anion channel (IMAC). IMAC is inhibited by matrix Mg2+, matrix H+, N,N'-dicyclohexycarbodiimide, mercurials and amphiphilic amines such as propranolol. Most of these agents react with a number of different mitochondrial proteins and, therefore, more selective inhibitors have been sought. In this paper, we report the discovery of a new class of inhibitors, triorganotin compounds, which block IMAC completely. One of the most potent, tributyltin (TBT) inhibits malonate uniport via IMAC 95% at 0.9 nmol/mg. The only other mitochondrial protein reported to react with triorganotins, the F1F0ATPase, is inhibited by about 0.75 nmol/mg. The potency of inhibition of IMAC increases with hydrophobicity in the sequence trimethyltin much less than triethyltin much less than tripropyltin less than triphenyltin less than tributyltin; which suggests that the binding site is accessible from the lipid bilayer. It has long been established that triorganotins are anionophores able to catalyze Cl-/OH- exchange; however, TBT is able to inhibit Cl- and NO3- transport via IMAC at doses below those required to catalyze rapid rates of Cl-/OH- exchange. Consistent with previous reports, the data indicate that about 0.8 nmol of TBT per mg of mitochondrial protein is tightly bound and not available to mediate Cl-/OH- exchange. We have also shown that the mercurials, p-chloromercuribenzene sulfonate and mersalyl, which only partially inhibit Cl- and NO3- transport can increase the IC50 for TBT 10-fold. This effect appears to result from a reaction at a previously unidentified mercurial reactive site. The inhibitory dose is also increased by raising the pH and inhibition by TBT can be reversed by S2- and dithiols but not by monothiols.lld:pubmed
pubmed-article:1716627pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:languageenglld:pubmed
pubmed-article:1716627pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:citationSubsetIMlld:pubmed
pubmed-article:1716627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1716627pubmed:statusMEDLINElld:pubmed
pubmed-article:1716627pubmed:monthSeplld:pubmed
pubmed-article:1716627pubmed:issn0021-9258lld:pubmed
pubmed-article:1716627pubmed:authorpubmed-author:BeavisA DADlld:pubmed
pubmed-article:1716627pubmed:authorpubmed-author:PowersM FMFlld:pubmed
pubmed-article:1716627pubmed:issnTypePrintlld:pubmed
pubmed-article:1716627pubmed:day15lld:pubmed
pubmed-article:1716627pubmed:volume266lld:pubmed
pubmed-article:1716627pubmed:ownerNLMlld:pubmed
pubmed-article:1716627pubmed:authorsCompleteYlld:pubmed
pubmed-article:1716627pubmed:pagination17250-6lld:pubmed
pubmed-article:1716627pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:meshHeadingpubmed-meshheading:1716627-...lld:pubmed
pubmed-article:1716627pubmed:year1991lld:pubmed
pubmed-article:1716627pubmed:articleTitleTriorganotins inhibit the mitochondrial inner membrane anion channel.lld:pubmed
pubmed-article:1716627pubmed:affiliationDepartment of Pharmacology, Medical College of Ohio, Toledo 43699-0008.lld:pubmed
pubmed-article:1716627pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1716627pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1716627lld:pubmed